Head-to-head · Cost-Efficiency Index
WeightRx vs Cielo
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
WeightRx
Cost-first shoppers who want the lowest published tirzepatide figure, if you are willing to complete intake before you can read the plan terms.
Visit WeightRxCielo
Shoppers comfortable committing to an undisclosed-structure 6-month plan for a flat, dose-independent price.
Visit CieloThe verdict
WeightRx takes it, leading the Cost-Efficiency Index 69 to 68. WeightRx is a telehealth provider publishing compounded semaglutide at $250/mo and compounded tirzepatide at $83/mo. Cielo still earns a C — Shoppers comfortable committing to an undisclosed-structure 6-month plan for a flat, dose-independent price.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs WeightRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | WeightRx | Cielo |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 68/100 |
| Semaglutide / mo | $250/mo (compounded) | $89/mo (all doses, 6-month plan, compounded) |
| Tirzepatide / mo | $83/mo (term not published, compounded) | $129/mo (all doses, 6-month plan, compounded) |
| Semaglutide / yr (modeled) | $3,000 | $1,068 |
| Tirzepatide / yr (modeled) | $996 | $1,548 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #109 | #115 |
WeightRx
69/100Where the value is
- The tirzepatide figure is published up front, and it is genuinely low against the field
- Both molecules are offered
- No membership charge is advertised alongside the medication rate
The tradeoffs
- The $83 monthly rate is advertised as '$83/month ($997/year)', which is twelve months of it — no month-to-month rate is separately published, and the terms state that a rate is locked for its full term
- Both product pages linked from the homepage return 404, so the plan terms cannot be read before intake
Cielo
68/100Where the value is
- Flat pricing regardless of dose for both semaglutide and tirzepatide, avoiding per-mg price escalation during titration
- Free physician consult and free shipping stated as included
- Claims 'Every batch tested', at least asserting quality-control testing exists
The tradeoffs
- The '6-month plan' mechanics are never explained — whether it's a one-time prepayment or a 6-month billing lock is unknown, which is exactly the kind of commitment term that should be disclosed before signup
- No pharmacy, medical director, or prescriber is named anywhere on the accessible site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.